ConductScience.org, home

Paper39006147

Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma.

Ucdal M and 2 others. Hepatol Forum, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma. Papers, record 39006147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39006147

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma.
PubMed
Journal
Hepatol Forum
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.35, provisional
iCite
Revised in PubMed
2024-07-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ucdal MMete
2Burus AAyse
3Celtikci BBasak

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References115

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127100897MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.Cell Death Dis2016https://conductscience.org/library/papers/27100897PubMed
226655911Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization.Cell Rep2015https://conductscience.org/library/papers/26655911PubMed
325822088Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.Nat Genet2015https://conductscience.org/library/papers/25822088PubMed
422811581Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.Clin Cancer Res2012https://conductscience.org/library/papers/22811581PubMed
526893654Prognostic significance of serum insulin-like growth factor-1 in patients with hepatocellular carcinoma following transarterial chemoembolization.Exp Ther Med2016https://conductscience.org/library/papers/26893654PubMed
628141967Telomerase Mechanism of Telomere Synthesis.Annu Rev Biochem2017https://conductscience.org/library/papers/28141967PubMed
717487939Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.J Pathol2007https://conductscience.org/library/papers/17487939PubMed
832194906LncRNA FLJ33360 accelerates the metastasis in hepatocellular carcinoma by targeting miRNA-140/MMP9 axis.Am J Transl Res2020https://conductscience.org/library/papers/32194906PubMed
930061739Molecular therapies and precision medicine for hepatocellular carcinoma.Nat Rev Clin Oncol2018https://conductscience.org/library/papers/30061739PubMed
1032173197Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors.Bioorg Med Chem Lett2020https://conductscience.org/library/papers/32173197PubMed
1128978124SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma.Oncotarget2017https://conductscience.org/library/papers/28978124PubMed
1226872014MicroRNA-361-5p Inhibits Cancer Cell Growth by Targeting CXCR6 in Hepatocellular Carcinoma.Cell Physiol Biochem2016https://conductscience.org/library/papers/26872014PubMed
1335406630Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma.Cells2022https://conductscience.org/library/papers/35406630PubMed
1429749382microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A.Cell Death Dis2018https://conductscience.org/library/papers/29749382PubMed
1529621773MicroRNA-214-5p Inhibits the Invasion and Migration of Hepatocellular Carcinoma Cells by Targeting Wiskott-Aldrich Syndrome Like.Cell Physiol Biochem2018https://conductscience.org/library/papers/29621773PubMed
169132148Oxidative phosphorylation and F(O)F(1) ATP synthase activity of human hepatocellular carcinoma.Biochem Mol Biol Int1996https://conductscience.org/library/papers/9132148PubMed
1723764751Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma.Br J Cancer2013https://conductscience.org/library/papers/23764751PubMed
1825647261MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN.Tumour Biol2015https://conductscience.org/library/papers/25647261PubMed
1928553614Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma.Front Oncol2017https://conductscience.org/library/papers/28553614PubMed
2021562580Cell-free nucleic acids as biomarkers in cancer patients.Nat Rev Cancer2011https://conductscience.org/library/papers/21562580PubMed

See all 115 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
39557956High expression of BBOX1 in paracancerous tissue is associated with poor prognosis in hepatocellular carcinoma patients.Sci Rep2024https://conductscience.org/library/papers/39557956

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39006147

GET https://conductscience.org/api/papers/v1/39006147/references?page=2